BIOTECH ACQUISITION COMPANY's ticker is BIOTU and the CUSIP is G1125A124. A total of 35 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $401 | -99.9% | 40,000 | 0.0% | 0.00% | – |
| Q3 2022 | $397,000 | +1.3% | 40,000 | 0.0% | 0.00% | – |
| Q2 2022 | $392,000 | -12.1% | 40,000 | -11.1% | 0.00% | – |
| Q1 2022 | $446,000 | -2.0% | 45,000 | 0.0% | 0.00% | – |
| Q4 2021 | $455,000 | +0.7% | 45,000 | 0.0% | 0.00% | – |
| Q3 2021 | $452,000 | -68.5% | 45,000 | -68.4% | 0.00% | -100.0% |
| Q2 2021 | $1,434,000 | +1.9% | 142,280 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,407,000 | – | 142,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 12,968 | $130 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 210 | $2,106 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 40,000 | $401 | 0.00% |
| MORGAN STANLEY | 551 | $5,527 | 0.00% |
| Tower Research Capital LLC (TRC) | 103 | $1 | 0.00% |